These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29676340)

  • 21. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
    Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
    J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical identification and image analysis quantification of oestrogen and progesterone receptors in canine and feline meningioma.
    Mandara MT; Ricci G; Rinaldi L; Sarli G; Vitellozzi G
    J Comp Pathol; 2002; 127(2-3):214-8. PubMed ID: 12354535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
    Barresi V; Alafaci C; Salpietro F; Tuccari G
    Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AKT2 expression in histopathologic grading and recurrence of meningiomas.
    Wang Q; Fan SY; Qian J; Wang JY; Lu YC; Hu GH; Luo C
    Eur J Surg Oncol; 2014 Sep; 40(9):1056-61. PubMed ID: 24656454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiomatous meningioma: a clinicopathologic study of 38 cases.
    Hasselblatt M; Nolte KW; Paulus W
    Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time.
    Kakinuma K; Tanaka R; Onda K; Takahashi H
    Acta Neurochir (Wien); 1998; 140(1):26-31; discussion 31-2. PubMed ID: 9522904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Ki-67 and p53 in meningiomas.
    Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
    Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of morphologically benign biologically aggressive meningiomas.
    Rao S; Sadiya N; Doraiswami S; Prathiba D
    Neurol India; 2009; 57(6):744-8. PubMed ID: 20139503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation potential of spinal meningiomas.
    Roser F; Nakamura M; Bellinzona M; Ritz R; Ostertag H; Tatagiba MS
    Eur Spine J; 2006 Feb; 15(2):211-5. PubMed ID: 15926055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting meningioma grades and pathologic marker expression via deep learning.
    Chen J; Xue Y; Ren L; Lv K; Du P; Cheng H; Sun S; Hua L; Xie Q; Wu R; Gong Y
    Eur Radiol; 2024 May; 34(5):2997-3008. PubMed ID: 37853176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
    Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
    Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunocytochemical study of progesterone receptor in human meningioma.
    Perrot-Applanat M; Groyer-Picard MT; Kujas M
    Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas.
    Maes L; Lippens E; Kalala JP; de Ridder L
    Cell Prolif; 2005 Feb; 38(1):3-12. PubMed ID: 15679862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
    Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
    Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
    Lee SH; Lee YS; Hong YG; Kang CS
    APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.